Research output per year
Research output per year
Equipments Details
Description
The Monoclonal Antibody Facility (MABF) provides custom monoclonal antibody production and purification to researchers at MD Anderson and beyond. The main focus of the facility is to produce high-affinity antibodies in a high-throughput and effective manner, while concentrating on quality of product and service, as well as saving time and money for potential users.
Fiber Cell Bioreactor
Hybridoma Development
Ascites production
Antibody purification (FPLC)
Antibody purification (Protein A)
Small scale purification
Mycoplasma Test (MycoAlert)
F(ab)2 Production
Recloning-Subcloning
Invitro Supernatant Production
mAB-Biotinylation
Stock of hybridoma
Fiber Cell Bioreactor
Hybridoma Development
Ascites production
Antibody purification (FPLC)
Antibody purification (Protein A)
Small scale purification
Mycoplasma Test (MycoAlert)
F(ab)2 Production
Recloning-Subcloning
Invitro Supernatant Production
mAB-Biotinylation
Stock of hybridoma
Fingerprint
Explore the research areas in which this equipment has been used. These labels are generated based on the related outputs. Together they form a unique fingerprint.
-
Lysine acetylation of NKG2D ligand Rae-1 stabilizes the protein and sensitizes tumor cells to NKG2D immune surveillance
Hu, J., Xia, X., Zhao, Q. & Li, S., Apr 1 2021, In: Cancer Letters. 502, p. 143-153 11 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancer
Yang, W. L., Lu, Z., Guo, J., Fellman, B. M., Ning, J., Lu, K. H., Menon, U., Kobayashi, M., Hanash, S. M., Celestino, J., Skates, S. J. & Bast, R. C., Feb 15 2020, In: Cancer. 126, 4, p. 725-736 12 p.Research output: Contribution to journal › Article › peer-review
16 Scopus citations -
Uso de plasma de convalecientes para tratamiento de covid-19 historia y evidencia
Translated title of the contribution :Use of convalescent plasma for the treatment of COVID-19: History and evidence Research output: Contribution to journal › Editorial › peer-review
5 Scopus citations